How Can NGS Help Prepare for Respiratory Viruses Season?
Steven Henck, PhD
Reliable, sensitive, and scalable genomic tools are critical to combating existent and emerging infectious diseases
multiplex
Expanding Access to Genomic Testing for Cancer Patients
Morgana Moretti, PhD
Overcoming budget constraints can ensure equal access to genomic medicine to improve cancer care
How To Optimize Your Multiplex Testing for Diagnostics Applications
Fortis Life Sciences
Custom reagents for multiplex PCR assays may be the missing ingredients for your infectious disease panel
Humans versus Pathogens: COVID-19 and Beyond
Zahraa Chorghay, PhD
Advances in COVID-19 detection can also give us a fighting chance against other pathogens
Enhanced PCR Capabilities with Digital PCR
Kristin Fathe, PhD
High Definition PCR can expand the multiplexing of digital PCR tenfold
Stuck between Syndromic and Single-Target Testing? Flex Testing May Be the Answer
Josh Griffith
Flex testing allows labs to run full syndromic panels without paying for every result
Navigating Flu Season during the COVID-19 Pandemic
Arvind Kothandaraman, MBS
Combination tests can detect and differentiate SARS-CoV-2, influenza A and B, and respiratory syncytial viruses
Multiplex Testing: A Valuable Resource for the 2021–2022 Flu Season
Bruno Larida, MS, MBA
With a new flu season and lessening COVID-19 restrictions, multiplex testing can improve turnaround times
Battling COVID-19 and Bracing for the Flu: How Molecular Tests Can Help
Sherry Dunbar, PhD, MBA
Rapid, multiplex molecular tests will give labs flexibility and scalability as they plan for the upcoming flu season
Multiplexing: A Better Approach to Point-of-Care Diagnostics
Today's Clinical Lab
A comparison of multiplex POC assays available for diagnostics